Investor's Business Daily
financeLean Left
Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beattranslating…
Biotech leader Kiniksa stock is poised to hit a fresh buy point after shares soared 25% in response to better-than-expected sales numbers.
The post Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat appeared first on Investor's Business…
Keywords#Buy Point#Leader Kiniksa#Hit#Poised#Kiniksa Poised